Satake, Hironaga http://orcid.org/0000-0001-7629-6803
Sagawa, Tamotsu
Fujikawa, Koshi
Hatachi, Yukimasa
Yasui, Hisateru
Kotaka, Masahito
Kato, Takeshi
Tsuji, Akihito
Article History
Received: 10 April 2018
Accepted: 27 August 2018
First Online: 30 August 2018
Compliance with ethical standards
:
: Hironaga Satake has received honoraria from Bayer, Chugai Pharma, Eli Lilly Japan, Merck Serono, Takeda, Taiho Pharmaceutical, and Yakult Honsha. Akihito Tsuji has received honoraria from Chugai Pharma, Takeda Pharmaceutical, Eli Lilly, Taiho Pharma, Bayer, Bristol-Myers Squibb Japan, Daiichi Sankyo, and Merck Serono. Masahito Kotaka has received honoraria from Chugai Pharma, Takeda Pharmaceutical, Yakult, Taiho Pharma, and Merck Serono. Takeshi Kato has received honoraria and/or research funding from Chugai Pharma, Takeda Pharmaceutical, Eli-Lilly, Taiho Pharma, Bayer, and Merck Serono. All remaining authors have declared no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.